RXO, Inc. (NYSE:RXO) Given Consensus Recommendation of “Reduce” by Analysts

RXO, Inc. (NYSE:RXOGet Free Report) has been assigned an average recommendation of “Reduce” from the twelve research firms that are covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price target among brokers that have covered the stock in the last year is $20.23.

A number of analysts recently commented on the company. Bank of America downgraded RXO from a “buy” rating to a “neutral” rating and decreased their price target for the company from $25.00 to $22.00 in a research report on Thursday, February 8th. Vertical Research downgraded RXO from a “buy” rating to a “hold” rating and set a $23.00 price target for the company. in a research report on Wednesday, January 10th. Benchmark reissued a “hold” rating on shares of RXO in a report on Friday, April 19th. Susquehanna increased their price objective on RXO from $15.00 to $16.00 and gave the company a “negative” rating in a report on Monday, March 25th. Finally, TD Cowen increased their price objective on RXO from $16.50 to $19.50 and gave the company a “market perform” rating in a report on Friday, February 9th.

Check Out Our Latest Analysis on RXO

RXO Stock Performance

Shares of RXO stock opened at $19.40 on Tuesday. The company has a market cap of $2.28 billion, a PE ratio of 485.00, a price-to-earnings-growth ratio of 6.81 and a beta of 1.08. RXO has a 52 week low of $16.94 and a 52 week high of $24.33. The business has a 50 day moving average price of $20.72 and a 200-day moving average price of $20.89. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.60.

RXO (NYSE:RXOGet Free Report) last issued its quarterly earnings data on Thursday, February 8th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.03 by $0.03. The firm had revenue of $978.00 million during the quarter, compared to the consensus estimate of $996.33 million. RXO had a return on equity of 6.11% and a net margin of 0.10%. The company’s quarterly revenue was down 12.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.28 earnings per share. Equities analysts anticipate that RXO will post 0.22 earnings per share for the current fiscal year.

Insider Transactions at RXO

In related news, major shareholder Mfn Partners, Lp purchased 100,000 shares of the business’s stock in a transaction dated Wednesday, April 24th. The stock was purchased at an average cost of $19.44 per share, with a total value of $1,944,000.00. Following the completion of the acquisition, the insider now directly owns 17,075,369 shares of the company’s stock, valued at $331,945,173.36. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders purchased 2,689,717 shares of company stock valued at $54,468,072 over the last three months. Company insiders own 1.80% of the company’s stock.

Hedge Funds Weigh In On RXO

A number of large investors have recently made changes to their positions in the stock. Douglas Lane & Associates LLC boosted its stake in RXO by 10.7% during the fourth quarter. Douglas Lane & Associates LLC now owns 2,579,390 shares of the company’s stock valued at $59,997,000 after buying an additional 248,883 shares during the period. Nisa Investment Advisors LLC boosted its stake in RXO by 65.6% during the third quarter. Nisa Investment Advisors LLC now owns 6,863 shares of the company’s stock valued at $135,000 after buying an additional 2,718 shares during the period. Barclays PLC boosted its stake in RXO by 299.9% during the third quarter. Barclays PLC now owns 270,766 shares of the company’s stock valued at $5,343,000 after buying an additional 203,052 shares during the period. GSA Capital Partners LLP boosted its stake in RXO by 325.2% during the third quarter. GSA Capital Partners LLP now owns 55,077 shares of the company’s stock valued at $1,087,000 after buying an additional 42,123 shares during the period. Finally, Motley Fool Asset Management LLC boosted its stake in RXO by 151.5% during the third quarter. Motley Fool Asset Management LLC now owns 403,658 shares of the company’s stock valued at $7,964,000 after buying an additional 243,137 shares during the period. 92.73% of the stock is owned by institutional investors.

RXO Company Profile

(Get Free Report

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Further Reading

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.